Complete Genomics (Nasdaq: GNOM) is popping higher, possibly on the acquisition of Navigenics, Inc., by Life Technologies (Nasdaq: LIFE), as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE